Hjem › Pankreaskreft › Colorado › Denver
Kliniske studier for Pankreaskreft i Denver, CO
13 studier for Pankreaskreft søker deltakere på steder i og rundt Denver (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
The Vanguard Study: Testing a New Way to Screen for Cancer
RekruttererFrivillige helsepersonell ønskes velkommen
- Kaiser Permanente-Franklin, Denver
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
RekruttererFase 1
- Sarah Cannon Research Institute at HealthOne, Denver
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
RekruttererFase 3
- Investigative Site US071, Denver
Biospecimen Collection to Identify Gene Mutations for High Risk Pancreatic Cancer in Pediatric Patients, INSPPIRE 2 Study
RekruttererObservasjonsstudie
- University of Colorado, Denver
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
RekruttererFase 1
- Sarah Cannon Research Institute - Denver DDU, Denver
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
RekruttererFase 3
- AdventHealth Porter, Denver
A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors
RekruttererFase 1
- Sarah Cannon Research Institute, Denver
A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
RekruttererFase 1
- Sarah Cannon, SCRI Oncology Partners - Health One, Denver
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
RekruttererFase 1/2
- Sarah Cannon Research Institute, Denver
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
RekruttererFase 1/2
- Sarah Cannon Research Institute at HealthONE, Denver
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
RekruttererFase 2
- Ohio State University Telemedicine, Denver
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruttererObservasjonsstudie
- Massive Bio SYNERGY-AI site, Denver
American Hepato-Pancreato-Biliary Association (AHPBA) Pancreatic Irreversible Electroporation (IRE) Registry
RekruttererObservasjonsstudie
- University of Colorado, Denver
Pankreaskreft-studier i andre byer
- Houston, TX61 studier
- New York City, NY60 studier
- Boston, MA43 studier
- Nashville, TN39 studier
- Los Angeles, CA35 studier
- St. Louis, MO33 studier
- Arlington, VA33 studier
- Baltimore, MD31 studier
- San Antonio, TX31 studier
- Philadelphia, PA26 studier
- Tampa, FL26 studier
- Durham, NC24 studier
Andre studier i Denver
- Metastatisk kreft29 studier
- Brystkreft29 studier
- Ikke-småcellet lungekreft27 studier
- Multipelt myelom27 studier
- Kolorektal kreft23 studier
- Melanom19 studier
- Prostatakreft19 studier
- Kreft (alle typer)18 studier
- Eggstokkreft16 studier
- Lungekreft16 studier
- Endometriekreft15 studier
- Non-Hodgkins lymfom14 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.